Evropska unija - hrvaščina - EMA (European Medicines Agency)

roche registration gmbh  - glofitamab - lymphoma, large b-cell, diffuse - antineoplastična sredstva - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.

Evropska unija - hrvaščina - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - antineoplastična sredstva - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.

Evropska unija - hrvaščina - EMA (European Medicines Agency)

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - psi - za liječenje neupotrebljiva, bez udaljenih metastaza (koji na pozornici) potkožnog pretilih stanica tumora, koji se nalazi na razini ili distalno na lakat ili skočnog zgloba kuka, i neupotrebljiva, sobe метастатические uzeli stanice kože рангоута tumora kod pasa.

Evropska unija - hrvaščina - EMA (European Medicines Agency)

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastični agensi - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Evropska unija - hrvaščina - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastična sredstva - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Bosna in Hercegovina - hrvaščina - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - pentaeritritil tetranitrat - tableta sa modifikovanim oslobađanjem - 80 mg/1 tableta - 1 tableta sa modifikovanim oslobađanjem sadrži: 80 mg pentaeritritil tetranitrata

Evropska unija - hrvaščina - EMA (European Medicines Agency)

roche registration gmbh - mosunetuzumab - limfom, folikularni - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

Bosna in Hercegovina - hrvaščina - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - pentaeritritil tetranitrat - tableta sa modifikovanim oslobađanjem - 80 mg/1 tableta - 1 tableta sa modifikovanim oslobađanjem sadrži: 80 mg pentaeritritil tetranitrata

Črna gora - hrvaščina - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"hoffmann-la roche ltd" d.s.d. podgorica - mosunetuzumab - koncentrat za rastvor za infuziju - 1mg

Črna gora - hrvaščina - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"hoffmann-la roche ltd" d.s.d. podgorica - mosunetuzumab - koncentrat za rastvor za infuziju - 30mg